Logo

Epic Sciences

Medicare Covering Epic Sciences ctDNA Breast Cancer Panel, MDxHealth's Select MDx Test

Medicare is covering the 56-gene ctDNA panel that forms one component of the DefineMBC multiomic liquid biopsy test.

Epic Sciences Raises $43M in Series F Round

Epic will use the funds to further develop its multi-analyte DefineMBC liquid biopsy and expand into other business areas.

Epic Sciences, Biosplice Therapeutics Partner on Multiomic Profiling for Cancer Trials

Biosplice will use Epic's liquid biopsy platform in several clinical trials, including for its Cirtuvivint investigative drug for solid tumors.

Epic Sciences, USC Michelson Center Sign Licensing Agreement for Liquid Biopsy Research

Epic will access the center's liquid biopsy samples and expand its platform to in-depth characterization of cell-free fractions and circulating tumor cells.

Epic Sciences, Predicine to Offer Liquid Biopsy Service for Biopharma Customers

The companies said their partnership will allow pharmaceutical partners to measure both ctDNA and CTC biomarkers from a single blood draw when conducting drug trials.